Skip to main content

Table 1 Clinical characteristics of the study subjects

From: Effect of plasma polyunsaturated fatty acid levels on leukocyte telomere lengths in the Singaporean Chinese population

 

CAD cases

CAD controls

P

N = 711

N = 638

 

Age (years)

66.64 ± 7.84

66.37 ± 7.82

0.531

Telomere length (T/S ratio)

1.00 ± 0.23

1.02 ± 0.24

0.100

Plasma fatty acid (% of total)

 n-3 fatty acid (%)

2.63 (2.04, 3.69)

2.83 (2.11, 4.02)

0.013

 18:3 (n-3) ALA (%)

0.28 (0.21, 0.38)

0.28 (0.22, 0.38)

0.310

 20:5 (n-3) EPA (%)

0.39 (0.31, 0.49)

0.42 (0.32, 0.53)

0.002

 22:6 (n-3) DHA (%)

1.92 (1.38, 2.79)

2.02 (1.45, 3.05)

0.020

 n-6 fatty acid (%)

45.07 ± 4.68

45.43 ± 4.81

0.165

 18:2(n-6) LA (%)

36.14 ± 4.63

36.43 ± 4.68

0.252

 18:3(n-6) GLA (%)

0.19 (0.13, 0.29)

0.19 (0.13, 0.29)

0.824

 20:3(n-6) DGLA (%)

0.88 (0.67, 1.13)

0.87 (0.69, 1.10)

0.652

 20:4(n-6) AA (%)

7.57 ± 1.68

7.67 ± 1.79

0.328

 n6:n3 ratio

17.02 (11.98, 22.10)

16.14 (10.93, 21.62)

0.053

 Gender (%male)

459 (64.56%)

401 (62.85%)

0.516

rs529143

  

0.759

 AA

522 (75.98%)

461 (74.47%)

 

 AC

155 (22.56%)

150 (24.23%)

 

 CC

10 (1.46%)

8 (1.29%)

 

 MAF

0.127

0.134

 
  1. Data was presented as Mean ± Standard Deviation (SD) for normally distributed variables, median (interquartile range) for non-normally distributed variables or N (%) for categorical variables
  2. ALA α-Linolenic acid; EPA Eicosapentaenoic acid; DHA Docosahexaenoic acid; LA Linoleic acid; GLA γ-Linolenic acid; DGLA Dihomo-γ-linolenic acid; AA Arachidonic acid; MAF Minor allele frequency